Hot off of a $210M Se­ries B, Umo­ja breaks ground in Col­orado on CAR-T site

Boul­der Coun­ty, CO, is get­ting a new man­u­fac­tur­ing fa­cil­i­ty, and it will come from a Seat­tle on­col­o­gy com­pa­ny fo­cused on CAR T-cell im­munother­a­pies.

Umo­ja Bio­phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER